Catalogo dei prodotti della ricerca

CATTARINO, SUSANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.101
EU - Europa 653
AS - Asia 444
SA - Sud America 14
AF - Africa 13
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.232
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.091
IT - Italia 319
SG - Singapore 169
CN - Cina 126
IN - India 90
SE - Svezia 83
DE - Germania 64
FI - Finlandia 64
UA - Ucraina 36
GB - Regno Unito 20
ID - Indonesia 19
BG - Bulgaria 13
TG - Togo 12
CA - Canada 9
IR - Iran 8
KR - Corea 8
CL - Cile 7
HK - Hong Kong 7
RU - Federazione Russa 7
AU - Australia 6
CH - Svizzera 6
NO - Norvegia 6
IL - Israele 5
LT - Lituania 5
AR - Argentina 4
IE - Irlanda 4
NL - Olanda 4
PH - Filippine 4
RO - Romania 4
BE - Belgio 3
ES - Italia 3
LU - Lussemburgo 3
EE - Estonia 2
FR - Francia 2
JP - Giappone 2
PE - Perù 2
BD - Bangladesh 1
BR - Brasile 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
IQ - Iraq 1
KG - Kirghizistan 1
LV - Lettonia 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
SC - Seychelles 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 3.232
Salva come PNG Salva come JPEG
Città #
Fairfield 415
Woodbridge 173
Ashburn 162
Seattle 130
Rome 124
Cambridge 121
Singapore 120
Chandler 115
Wilmington 113
Houston 107
Ann Arbor 101
Santa Clara 62
San Paolo di Civitate 59
Princeton 52
Plano 44
Lawrence 38
Millbury 31
San Diego 29
Beijing 28
Munich 27
Falkenstein 19
Helsinki 19
Jakarta 19
Hefei 18
Andover 17
Milan 17
New York 17
Boston 13
Sofia 13
Jacksonville 12
Lomé 12
Falls Church 10
Dearborn 9
Kunming 9
Philadelphia 9
Norwalk 8
Des Moines 7
Nanjing 7
Phoenix 7
Cagliari 6
Moscow 6
Oslo 6
Hong Kong 5
Jinan 5
London 5
Los Angeles 5
Ramat Gan 5
Southend 5
Toronto 5
Chongqing 4
Dublin 4
Federal 4
Fremont 4
Fuzhou 4
Grafing 4
Indiana 4
Lappeenranta 4
Ottawa 4
Paliano 4
Portoferraio 4
San Mateo 4
Boardman 3
Brunnen 3
Brussels 3
Chengdu 3
Foligno 3
Hyderabad 3
Madrid 3
Modena 3
Nanchang 3
Nowon-gu 3
Olongapo City 3
Pisa 3
Seongbuk-gu 3
Sona 3
Springfield 3
Wuhan 3
Aldershot 2
Amsterdam 2
Baotou 2
Bern 2
Bremen 2
Brisbane 2
Buffalo 2
Bühl 2
Crema 2
Eboli 2
Fort Worth 2
Genoa 2
Guangzhou 2
Itri 2
Lima 2
Manchester 2
Melbourne 2
Melendugno 2
Mumbai 2
Naples 2
Napoli 2
Nettuno 2
Provo 2
Totale 2.488
Salva come PNG Salva come JPEG
Nome #
Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer 113
A perspective of immunotherapy for prostate cancer 96
Beyond the immune suppression: the immunotherapy in prostate cancer 90
Correlation between the presence of the nuclear AR-V7 androgen receptor and clinical evolution of prostate cancer: in vitro analysis of a combination of compounds targeting PI3K 89
A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer 89
Use of Multiparametric MR with Neurovascular Bundle Evaluation to Optimize the Oncological and Functional Management of Patients Considered for Nerve-Sparing Radical Prostatectomy 87
Laparoscopic versus open radical prostatectomy in high prostate volume cases: impact on oncological and functional results 84
Androgen receptor variant 7 (AR-V7) in sequencing therapeutic agents for castratrion resistant prostate cancer: A critical review 83
Outcomes of a virtual-reality simulator-training programme on basic surgical skills in robot-assisted laparoscopic surgery 81
Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer 78
Prognostic value of inflammation in prostate cancer progression and response to therapeutic: A critical review 78
Prostate-specific antigen increase during dutasteride to indicate the need for prostate biopsy: influence of prostatic inflammation 76
Use of multiparametric MR with neurovascular bundle evaluation to optimize the oncological and functional management of patients considered for nerve sparing radical prostatectomy 73
Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy 72
Prognostic predictors in prostate cancer cases with biochemical progression after surgery treated with intermittent androgen deprivation (IAD) 72
USE OF MULTIPARAMETRIC MR WITH NEUROVASCULAR BUNDLE EVALUATION TO OPTIMIZE THE ONCOLOGICAL AND FUNCTIONAL MANAGEMENT OF PATIENTS CONSIDERED FOR NERVE SPARING RADICAL PROSTATECTOMY 72
Prostate cancer unit for an optimal management of prostate cancer unit. ["Prostate cancer unit" per un management ottimale dei pazienti con tumore prostatico] 72
Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: Analysis in primary cell cultures of human prostate carcinoma 71
Pros-IT CNR: an Italian prostate cancer monitoring project 69
Determination of the time for maximal response to neoadjuvant hormone therapy for prostate cancer using magnetic resonance with spectroscopy (MRSI) and dynamic contrast enhancement (DCEMR) 67
Intermittent androgen deprivation in prostate cancer cases with biochemical progression after radical prostatectomy: Are we ready to treat? 66
Current diagnostic procedure on neuroendocrine differentiation of prostate cancer 66
null 65
Update on screening in prostate cancer based on recent clinical trials 64
Supernumerary kidney laparoscopically treated 64
PROGNOSTIC PREDICTORS IN PROSTATE CANCER CASES WITH BIOCHEMICAL PROGRESSION AFTER SURGERY TREATED WITH INTERMITTENT ANDROGEN DEPRIVATION (IAD) 63
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 62
Treatment paths for localised prostate cancer in Italy: the results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 62
Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery 61
null 60
The emerging role of targeted therapy in renal cell carcinoma (RCC): Is it time for a neoadjuvant or an adjuvant approach? 59
Trends in scientific publications related to the field of onco-urology over the past 10 years 59
Role of neuroendocrine cells in prostate cancer progression 58
Compared efficacy of adjuvant intravesical bcg-tice vs. bcg-rivm for high-risk non-muscle invasive bladder cancer (nmibc). a propensity score matched analysis 58
The Dilemma of Early Diagnosis for a Clinically Relevant Prostate Cancer: The Role of Urologist 55
Cryotherapy for prostate cancer 54
Thulium Laser Supported Nephron Sparing Surgery for Renal Cell Carcinoma 53
Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy 52
Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center study 47
Role of magnetic resonance spectroscopic imaging ([H-1]MRSI) and dynamic contrast-enhanced MRI (DCE-MRI) in identifying prostate cancer foci in patients with negative biopsy and high levels of prostate-specific antigen (PSA) 47
Neuroendocrine target therapies for prostate cancer 46
A molecular analysis of the human polyomaviruses DNA sequences in prostate cancer patients reveals a high frequency of JCV detection: preliminary results 42
Tissue expression of androgen receptor splice variant 7 at radical prostatectomy predicts risk of progression in untreated nonmetastatic prostate cancer 41
Oral ethinylestradiol in castration resistent prostate cancer: 10 year experience 38
Comparison of Different Invasive Devices for the Treatment of Urinary Incontinence after Radical Prostatectomy 34
Translation and validation of the Italian version of the Wisconsin Stone Quality of Life Questionnaire (I-WISQOL) for assessing quality of life in patients with urolithiasis 32
Comparative Effect of Finasteride and Dutasteride on Chromogranin A Levels 31
PROSTATE CANCER UNITS FOR THE OPTIMAL MANAGEMENT OF PROSTATE CANCER 31
THE ONCOGENIC POTENTIAL OF HUMAN POLYOMAVIRUSIIK IN PROSTATE CANCER 29
null 28
How the analysis of the pathogenetic variants of DDR genes will change the management of prostate cancer patients 27
Is It Time to Anticipate the Use of PARP Inhibition in Prostate Cancer Patients? 23
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with non-metastatic and metastatic prostate cancer: a meta-analysis and systematic review 20
INTERMITTENT VERSUS CONTINUOUS ANDROGEN DEPRIVATION THERAPY FOR BIOCHEMICAL PROGRESSION AFTER PRIMARY THERAPY IN HORMONE-SENSITIVE NON-METASTATIC PROSTATE CANCER: COMPARATIVE ANALYSIS IN TERMS OF CRPC-M0 PROGRESSION 19
Comparative prospective and longitudinal analysis on the platelet-to-lymphocyte, neutrophil-to-lymphocyte, and albumin-to-globulin ratio in patients with non-metastatic and metastatic prostate cancer 17
Infiammazione e patologie croniche della prostata: il legame è causale? (Capitolo 7) 17
MRI ultrasound fusion biopsy in prostate cancer detection: Are randomized clinical trials reproducible in everyday clinical practice? 17
Prognostic Value of Albumin to Globulin Ratio in Non-Metastatic and Metastatic Prostate Cancer Patients: A Meta-Analysis and Systematic Review 16
DDR genes analysis and PARP-inhibitors therapy as tailored management in metastatic prostate cancer: achieved answers, open questions and future perspectives 15
MRI ultrasound fusion biopsy in prostate cancer detection: Are randomized clinical trials reproducible in everyday clinical practice? 14
null 14
Exosome Analysis in Prostate Cancer: How They Can Improve Biomarkers’ Performance 12
Translation and validation of the Italian version of the Wisconsin Stone Quality of Life Questionnaire (I-WISQOL) for assessing quality of life in patients with urolithiasis 12
null 12
Regenerative medicine-based treatment of stress urinary incontinence with stem cells: a systematic review and meta-analysis 9
GNRH-agonist or antagonist in the treatment of prostate cancer: a comparision based on oncological results 8
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide 8
null 8
null 4
Totale 3.411
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.376
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.376
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020527 0 0 0 0 0 112 133 91 83 52 30 26
2020/2021255 21 28 6 38 33 13 12 21 23 34 19 7
2021/2022483 11 31 54 4 53 31 6 53 33 46 59 102
2022/2023536 94 125 37 37 53 44 18 31 48 17 19 13
2023/2024358 20 51 15 28 32 43 12 49 1 40 37 30
2024/2025366 23 50 56 81 96 60 0 0 0 0 0 0
Totale 3.411